Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Intensive Chemotherapy for Patients Greater Than or Equal To 10 Years of Age With Newly Diagnosed High Stage Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumors (PNET) and Ependymoma: A Feasibility Study of an Intensive Induction Chemotherapy Regimen Followed by Standard Irradiation

NCT00006258 is registered in ClinicalTrials.gov with Children's Hospital Los Angeles as lead sponsor.

NCT NCT00006258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Intensive Chemotherapy for Patients Greater Than or Equal To 10 Years of Age With Newly Diagnosed High Stage Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumors (PNET) and Ependymoma: A Feasibility Study of an Intensive Induction Chemotherapy Regimen Followed by Standard Irradiation
Lead sponsor
Children's Hospital Los Angeles
Phase
Phase 2
Overall status
Completed
Start date
November 30, 1997
Completion date
January 31, 2005
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors